TrialCardiology journal2021

Low dose of ROSuvastatin in combination with EZEtimibe effectively and permanently reduce low density lipoprotein cholesterol concentration independently of timing of administration (ROSEZE): A randomized, crossover study - preliminary results.

Karolina Obońska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.